Missing/wrong data?
Log in to edit
Safety and durability of effect of contralateral-eye administration of AAV2 gene therapy in patients with childhood-onset blindness caused by RPE65 mutations: a follow-on phase 1 trial.
scientific article published on 30 June 2016
Author/s
author: Eric A Pierce, Katherine A. High, Alberto Auricchio, Francesca Simonelli, Albert M Maguire, Kathleen Marshall, Federico Mingozzi, Bart Leroy
Work details
Publication date
June 30, 2016
-
-
Language
English
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.